​

AlloVir (ALVR) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

ALVR Stock Rating

AlloVir stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (57.14%), 2 Hold (28.57%), 1 Sell (14.29%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 2 4 Strong Sell Sell Hold Buy Strong Buy

ALVR Price Target Upside V Benchmarks

TypeNameUpside
StockAlloVir-
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$9.81$9.81$9.81
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 25--1--1
Jan, 25--1--1
Dec, 24--1--1
Nov, 24--22-4
Oct, 24--2215
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 26, 2023Raymond JamesStrong BuyStrong Buyhold
May 18, 2022Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-45 $-36 $-27 $-18 $-9 $0 Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.54$-2.74$-1.83$-0.01----
Avg Forecast$-1.96$-2.53$-40.14$-9.66$-7.36$-10.12$-10.58$-10.58
High Forecast$-1.96$-2.53$-37.16$-9.66$-5.74$-10.12$-10.58$-10.58
Low Forecast$-1.96$-2.53$-42.44$-9.66$-8.98$-10.12$-10.58$-10.58
Surprise %29.59%8.30%-95.44%-99.90%----

Revenue Forecast

$0 $300M $600M $900M $1B $2B Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported--------
Avg Forecast$375.00K$382.50K-$64.38M$2.61M$160.23M$770.77M$1.17B
High Forecast$375.00K$382.50K-$64.38M$2.61M$160.23M$770.77M$1.17B
Low Forecast$375.00K$382.50K-$64.38M$2.61M$160.23M$770.77M$1.17B
Surprise %--------

Net Income Forecast

$-5B $-4B $-3B $-2B $-900M $0 Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-68.38M$-171.96M$-190.42M$-58.77M----
Avg Forecast$-204.30M$-263.26M$-4.14B$-1.01B$-765.86M$-1.05B$-1.10B$-1.10B
High Forecast$-204.30M$-263.26M$-3.87B$-1.01B$-597.74M$-1.05B$-1.10B$-1.10B
Low Forecast$-204.30M$-263.26M$-4.42B$-1.01B$-933.98M$-1.05B$-1.10B$-1.10B
Surprise %-66.53%-34.68%-95.40%-94.15%----

ALVR Forecast FAQ

Is AlloVir stock a buy?

AlloVir stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that AlloVir is a favorable investment for most analysts.

What is AlloVir's price target?

AlloVir's price target, set by 7 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $9.81.

How does AlloVir stock forecast compare to its benchmarks?

AlloVir's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for AlloVir over the past three months?

  • February 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is AlloVir’s EPS forecast?

AlloVir's average annual EPS forecast for its fiscal year ending in December 2025 is $-7.36, marking a 73500.00% increase from the reported $-0.01 in 2024. Estimates for the following years are $-10.12 in 2026, $-10.58 in 2027, and $-10.58 in 2028.

What is AlloVir’s revenue forecast?

AlloVir's average annual revenue forecast for its fiscal year ending in December 2025 is $2.61M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $160.23M, followed by $770.77M for 2027, and $1.17B for 2028.

What is AlloVir’s net income forecast?

AlloVir's net income forecast for the fiscal year ending in December 2025 stands at $-766M, representing an 1203.17% increase from the reported $-58.769M in 2024. Projections indicate $-1.053B in 2026, $-1.101B in 2027, and $-1.101B in 2028.